Fate Therapeutics (FATE) Bɛn Dɛŋɛn Akɔc
Fate Therapeutics
Bɛ̈ny cɔk aya$2.36Aciic 25 Sep 2026 19:59 UTC
Change+0.85%
AI forecast: FATE
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
Fate Therapeutics, Inc. provides biopharmaceutical services. The company researches and develops treatments for tissue repair and regeneration using stem cells. The company operates in the United States.
